#clinic
Latest news and interesting information about clinic.
Donor blood tests explained
Donor blood testing process: ABO/RH typing, antibody screening, crossmatch. Safety ensured by international standards.
Ali Ahmadov's son appointed chief physician
Fikrat Ahmadov appointed chief physician at the Republican Clinical Urological Hospital. He leaves the Nizami Medical Center for this new role.
Woman Dies After Falling from Plane Stairs in Brazil
72-year-old woman dies after falling from plane stairs at Congonhas Airport in São Paulo, Brazil. She suffered brain hemorrhage and passed away two days later.
Dismissed Colonel Faces Criminal Charges
Colonel Oktay Babayev accused of fraud after dismissal, allegedly took 30,000 manat bribe.
New pick-up spots created at 2 locations in Baku
Baku creates new pick-up/drop-off spots near hospitals on Hasan bey Zardabi and Kazim Kazimzade streets, removing some parking.
Cellectar Plans Phase 3 Trial for WM After BTKi
Cellectar Biosciences reports promising Phase 2 results for iopofosine I 131 in Waldenström macroglobulinemia after BTKi therapy, plans Phase 3 trial.
Moderna Partners with CEPI for BDBV Ebola Vaccine
Moderna partners with CEPI to develop a BDBV Ebola vaccine, with up to $50 million in funding.
CRISM Secures £99,902 Grant for Cancer
CRISM Therapeutics receives £99,902 grant from Invest NI for docetaxel-ChemoSeed prostate cancer program development.
Could GLP-1 drugs be oncology's next big opportunity?
New research suggests GLP-1 drugs may play a role in cancer prevention and treatment, opening a potential new frontier for these popular therapies.
Revolution Medicines Phase 3 Trial Results
Revolution Medicines announces positive Phase 3 trial results for daraxonrasib in pancreatic cancer, showing significant survival benefit.
Novartis radiopharma drug shows promise
Novartis experimental actinium-based radiopharma drug shows anti-tumor activity in prostate cancer, including in patients previously treated with Pluvicto.
Mineralys Presents Lorundrostat Data in Kidney Patients
Mineralys (MLYS) reveals new clinical data for lorundrostat showing efficacy in hypertensive patients with chronic kidney disease.
Immunome presents phase 3 trial results for desmoid tumor drug
Immunome announces phase 3 results for varegacestat in desmoid tumors: 84% reduction in progression risk, 56% objective response rate.
Wolfe Research Downgrades Boston Scientific
Wolfe Research downgraded Boston Scientific to Peer Perform as PFA and Watchman growth falter. Analyst sees 7% growth in 2027, stock in low $50s.
Entera Bio Presents Clinical Data on Osteoporosis Drug
Entera Bio presents clinical data for osteoporosis drug EB613. Presentation at ENDO 2026 conference.
Medicus Pharma secures up to $22M financing facility
Medicus Pharma secures up to $22M in structured financing. The biotech firm gets $12M immediate capital and $10M milestone-based funds.
Oppenheimer Starts Adlai Nortye at Outperform
Oppenheimer starts Adlai Nortye with Outperform rating and $32 target. Key pipeline assets AN4035 and AN8025 highlighted.
Hippocratic AI hits 10 million patient calls
Hippocratic AI's Polaris system hits 10 million patient calls on DigitalOcean with 99.9% safety score. Over 180 million interactions handled.
Ernexa Advances ERNA-101 Toward Q3 IND Filing
Ernexa Therapeutics advances ERNA-101 toward Q3 IND filing. The company has completed process development and moved to GMP manufacturing for clinical trials.
VolitionRx Q1 Revenue Surges 300%, Nears Vet Milestone
VolitionRx Q1 revenue jumps 300% to $1M. Company nears vet milestone with Nu.Q test. Stock up 18%. Analyst targets $16-$24.
FP-001 42 mg Clinical Trial Completed
Foresee Pharmaceuticals completes Phase 3 trial for FP-001 42 mg for precocious puberty. FDA submission planned for 2026. CAMCEVI 21mg approved in Europe.
Junshi Biosciences completes phase III lung cancer study
Junshi Biosciences completes phase III lung cancer study. Toripalimab combination shows promising results in resectable stage II-III NSCLC.
Brother of Executive Head Appointed to High Position - PHOTO
Cavid Pashayev appointed Director of Sabunchu Medical Center. His brother Elvin Pashayev is head of Gakh Executive Authority.
Poolbeg Pharma Gets FDA Feedback on POLB 001
Poolbeg Pharma receives FDA feedback on POLB 001 for cancer immunotherapy-induced Cytokine Release Syndrome.
Morgan Stanley Initiates Avalyn Pharma with Overweight
Morgan Stanley initiates Avalyn Pharma with Overweight rating and $53 target. The inhaled therapies AP01 and AP02 show promise in pulmonary fibrosis.
Goldman Sachs Backs Seaport Stock
Goldman Sachs initiates coverage on Seaport Therapeutics with an Early-Stage Biotech rating. Learn about the company's platform and financials.
Benitec Biopharma gene therapy stock shows clinical promise
Benitec Biopharma gene therapy stock shows clinical promise. BB-301 achieves 100% response rate in OPMD. Analysis on Bond.az.
Edwards Lifesciences SWOT: Rival's setback boosts stock
Edwards Lifesciences SWOT analysis: Rival's setback boosts stock. Explore market opportunities and risks in detail.
Jardine Matheson to Buy Australia's I-MED for $2.4B
Jardine Matheson acquires Australian medical imaging firm I-MED Radiology Network for $2.4 billion enterprise value.
Jardine Matheson to Buy Australia's I-MED in $2.4B Deal
Jardine Matheson acquires Australia's I-MED Radiology Network for $2.4B. Deal set to close in 2026.
...